Patent 7541471 was granted and assigned to Schering on June, 2009 by the United States Patent and Trademark Office.
The present invention relates to an improved process for preparing himbacine analogs. The compounds are useful as thrombin receptor antagonists. The improved process may allow for at least one of easier purification by crystallization, easier scalability, and improved process yield on the desired enantiomer.